Candriam Equities L Biotech.R USD Acc/ LU0942225912 /
| NAV9/20/2023 | Chg.-1.2400 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 235.7200USD | -0.52% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | - | - | - | - | - | - | - | - | - | - | - | 1.68 | - |
| 2014 | 8.32 | 7.40 | -9.88 | -5.03 | 2.83 | 10.18 | -3.18 | 11.14 | -1.05 | 9.67 | 3.04 | 0.65 | +36.60% |
| 2015 | 4.53 | 4.60 | 1.93 | -5.05 | 10.81 | 0.70 | 4.23 | -10.89 | -11.33 | 7.88 | 3.49 | 0.39 | +9.00% |
| 2016 | -23.19 | -4.52 | 3.75 | 3.75 | 5.66 | -8.35 | 12.63 | -2.32 | 4.04 | -12.67 | 9.19 | -2.77 | -18.88% |
| 2017 | 5.58 | 6.90 | 0.16 | 1.14 | -2.88 | 9.44 | 2.46 | 6.89 | 0.96 | -6.54 | 0.19 | 1.52 | +27.71% |
| 2018 | 6.76 | -4.56 | -2.08 | -3.16 | 4.67 | 0.87 | 4.47 | 4.19 | -2.05 | -13.96 | 4.19 | -8.27 | -10.56% |
| 2019 | 13.20 | 3.62 | -0.50 | -4.89 | -4.42 | 9.49 | -2.14 | -2.31 | -4.46 | 11.26 | 12.03 | 2.85 | +36.03% |
| 2020 | -5.22 | -1.47 | -4.93 | 12.42 | 9.55 | 1.34 | -2.95 | 0.90 | 0.77 | -2.60 | 9.52 | 3.04 | +20.18% |
| 2021 | 1.87 | -2.55 | -4.22 | 2.77 | -2.21 | 6.41 | -1.41 | 3.95 | -4.19 | 0.21 | -4.33 | 2.46 | -1.91% |
| 2022 | -10.53 | -1.50 | 6.10 | -7.18 | -3.92 | 3.56 | 4.77 | 1.59 | -1.85 | 6.56 | 6.24 | -2.81 | -0.72% |
| 2023 | 2.98 | -5.61 | 0.31 | 2.33 | -0.88 | 1.49 | -0.51 | -0.16 | -2.38 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.46% | 13.21% | 17.58% | 20.99% | 23.54% |
| Sharpe ratio | -0.53 | 0.03 | 0.06 | -0.10 | 0.05 |
| Best month | +2.98% | +2.33% | +6.56% | +9.52% | +13.20% |
| Worst month | -5.61% | -2.38% | -5.61% | -10.53% | -13.96% |
| Maximum loss | -10.16% | -6.93% | -11.54% | -29.90% | -29.90% |
| Outperformance | -3.63% | - | -4.64% | +3.57% | +0.83% |
All quotes in USD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,802.2700 | +6.55% | +3.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 196.4300 | -2.35% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,830.4399 | +3.17% | -3.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,973.0100 | -1.35% | +13.63% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,079.5701 | -1.86% | +6.29% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 322.4400 | -1.94% | +9.07% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 288.0200 | -1.47% | +15.37% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 181.0200 | +1.47% | -3.93% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,607.4301 | +6.59% | +5.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 4,983.7998 | +4.99% | +4.19% | |
| Candriam Equities L Biotech.V US... | reinvestment | 527.8700 | +5.02% | +0.90% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 175.6800 | +2.96% | -4.17% | |
| Candriam Equities L Biotech.R US... | reinvestment | 235.7200 | +4.98% | +5.78% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 182.1800 | +3.28% | -1.85% | |
| Candriam Equities L Biotech.C US... | reinvestment | 739.1700 | +5.42% | +2.25% | |
| Candriam Equities L Biotech.C US... | paying dividend | 679.1400 | +5.39% | +2.15% |
Performance
| YTD | -2.68% | ||
|---|---|---|---|
| 6 Months | +2.14% | ||
| 1 Year | +4.98% | ||
| 3 Years | +5.78% | ||
| 5 Years | +27.84% | ||
| 10 Years | - | ||
| Since start | +135.72% | ||
| Year | |||
| 2022 | -0.72% | ||
| 2021 | -1.91% | ||
| 2020 | +20.18% | ||
| 2019 | +36.03% | ||
| 2018 | -10.56% | ||
| 2017 | +27.71% | ||
| 2016 | -18.88% | ||
| 2015 | +9.00% | ||
| 2014 | +36.60% | ||